1. Product Overview
1.1.
Market
Definition
1.2.
Scope
of the Market
1.2.1.
Markets
Covered
1.2.2.
Years
Considered for Study
1.2.3.
Key
Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1.
Overview
of the Market
3.2.
Overview
of Key Market Segmentations
3.3.
Overview
of Key Market Players
3.4.
Overview
of Key Regions/Countries
3.5.
Overview
of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global
Curative Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1.
By
Value
5.2. Market Share & Forecast
5.2.1.
By Type
(Biology Modifying Drugs, Gene Therapies, Cell Therapies)
5.2.2.
By
Indication (Cancer, Musculoskeletal Disorders, Neurodegenerative Diseases, Rare
Diseases, Hepatitis C, Others)
5.2.3.
By
End User (Pharmaceutical Companies, Academic & Research Institutions,
Others)
5.2.4.
By
Region
5.2.5.
By
Company (2023)
5.3. Market Map
6.
North
America Curative Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1.
By
Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2.
By
Indication
6.2.3.
By
End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1.
United
States Curative Therapeutics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By
Type
6.3.1.2.2.
By
Indication
6.3.1.2.3.
By
End User
6.3.2.
Canada
Curative Therapeutics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By
Type
6.3.2.2.2.
By
Indication
6.3.2.2.3.
By
End User
6.3.3.
Mexico
Curative Therapeutics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By
Type
6.3.3.2.2.
By
Indication
6.3.3.2.3.
By
End User
7.
Europe
Curative Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1.
By
Value
7.2. Market Share & Forecast
7.2.1.
By
Type
7.2.2.
By
Indication
7.2.3.
By
End User
7.2.4.
By
Country
7.3. Europe: Country Analysis
7.3.1.
Germany
Curative Therapeutics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By
Type
7.3.1.2.2.
By
Indication
7.3.1.2.3.
By
End User
7.3.2.
United
Kingdom Curative Therapeutics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By
Type
7.3.2.2.2.
By
Indication
7.3.2.2.3.
By
End User
7.3.3.
Italy
Curative Therapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By
Type
7.3.3.2.2.
By
Indication
7.3.3.2.3.
By
End User
7.3.4.
France
Curative Therapeutics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By
Type
7.3.4.2.2.
By
Indication
7.3.4.2.3.
By
End User
7.3.5.
Spain
Curative Therapeutics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By
Type
7.3.5.2.2.
By
Indication
7.3.5.2.3.
By
End User
8.
Asia Pacific
Curative Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1.
By
Value
8.2. Market Share & Forecast
8.2.1.
By
Type
8.2.2.
By
Indication
8.2.3.
By
End User
8.2.4.
By
Country
8.3. Asia Pacific: Country Analysis
8.3.1.
China
Curative Therapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By
Type
8.3.1.2.2.
By
Indication
8.3.1.2.3.
By
End User
8.3.2.
India
Curative Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By
Type
8.3.2.2.2.
By
Indication
8.3.2.2.3.
By
End User
8.3.3.
Japan
Curative Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By
Type
8.3.3.2.2.
By Indication
8.3.3.2.3.
By
End User
8.3.4.
South
Korea Curative Therapeutics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By
Type
8.3.4.2.2.
By
Indication
8.3.4.2.3.
By
End User
8.3.5.
Australia
Curative Therapeutics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By
Type
8.3.5.2.2.
By
Indication
8.3.5.2.3.
By
End User
9.
South
America Curative Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1.
By
Value
9.2. Market Share & Forecast
9.2.1.
By
Type
9.2.2.
By
Indication
9.2.3.
By
End User
9.2.4.
By
Country
9.3. South America: Country Analysis
9.3.1.
Brazil
Curative Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By
Type
9.3.1.2.2.
By
Indication
9.3.1.2.3.
By
End User
9.3.2.
Argentina
Curative Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By
Type
9.3.2.2.2.
By Indication
9.3.2.2.3.
By
End User
9.3.3.
Colombia
Curative Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By
Type
9.3.3.2.2.
By
Indication
9.3.3.2.3.
By
End User
10. Middle East and Africa Curative
Therapeutics Market Outlook
10.1.
Market
Size & Forecast
10.1.1. By Value
10.2.
Market
Share & Forecast
10.2.1. By Type
10.2.2. By Indication
10.2.3. By End User
10.2.4. By Country
10.3.
MEA:
Country Analysis
10.3.1. South Africa Curative Therapeutics
Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By
Type
10.3.1.2.2.
By
Indication
10.3.1.2.3.
By
End User
10.3.2. Saudi Arabia Curative Therapeutics
Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By
Type
10.3.2.2.2.
By
Indication
10.3.2.2.3.
By
End User
10.3.3. UAE Curative Therapeutics
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By
Type
10.3.3.2.2.
By Indication
10.3.3.2.3.
By
End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent
Development
12.2.
Mergers
& Acquisitions
12.3.
Product
Launches
13. Global Curative Therapeutics Market:
SWOT Analysis
14. Porter’s Five Forces Analysis
14.1.
Competition
in the Industry
14.2.
Potential
of New Entrants
14.3.
Power
of Suppliers
14.4.
Power
of Customers
14.5.
Threat
of Substitute Products
15. Competitive Landscape
15.1.
Pfizer, Inc.
15.1.1. Business
Overview
15.1.2. Company
Snapshot
15.1.3. Products
& Services
15.1.4. Financials
(As Reported)
15.1.5. Recent
Developments
15.1.6. Key Personnel
Details
15.1.7. SWOT
Analysis
15.2.
GlaxoSmithKline plc
15.3.
Sanofi S.A.
15.4.
Bluebird bio, Inc.
15.5.
Novartis AG
15.6.
Spark Therapeutics, Inc.
15.7.
Gilead Sciences, Inc.
15.8.
Sarepta Therapeutics, Inc.
15.9.
Vertex Pharmaceuticals Incorporated
15.10.
Alnylam Pharmaceuticals, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer